Michel Chrétien1, Nabil G Seidah, Ajoy Basak, Majambu Mbikay. 1. University of Ottawa, The Ottawa Hospital, Ottawa Health Research Institute, Chronic Disease Program, 725 Parkdale Avenue, Ottawa, Ontario, K1Y 4E9, Canada. mchretien@ohri.ca
Abstract
BACKGROUND: Limited endoproteolysis of precursor proteins is a common mechanism of production of functional proteins and peptides. In the secretory pathway of eukaryotic cells, this endoproteolysis is principally mediated by a family of calcium-dependent serine proteases, generically known as proprotein convertases. Altered expression of these enzymes in experimental animal models and in humans has been associated with numerous pathologies, including infertility, developmental defects, metabolic dysfunctions, cancer, cardiovascular diseases and infectious diseases. OBJECTIVE: To review experimental evidence of the therapeutic potential of proprotein convertase inhibitors or silencers. CONCLUSIONS: Several potent inhibitors have been developed and successfully tested. Their therapeutic use must await further improvements in potency, selectivity, cellular delivery and tissue targeting.
BACKGROUND: Limited endoproteolysis of precursor proteins is a common mechanism of production of functional proteins and peptides. In the secretory pathway of eukaryotic cells, this endoproteolysis is principally mediated by a family of calcium-dependent serine proteases, generically known as proprotein convertases. Altered expression of these enzymes in experimental animal models and in humans has been associated with numerous pathologies, including infertility, developmental defects, metabolic dysfunctions, cancer, cardiovascular diseases and infectious diseases. OBJECTIVE: To review experimental evidence of the therapeutic potential of proprotein convertase inhibitors or silencers. CONCLUSIONS: Several potent inhibitors have been developed and successfully tested. Their therapeutic use must await further improvements in potency, selectivity, cellular delivery and tissue targeting.
Authors: Yaowu He; Andreas Wortmann; Les J Burke; Janet C Reid; Mark N Adams; Ibtissam Abdul-Jabbar; James P Quigley; Richard Leduc; Daniel Kirchhofer; John D Hooper Journal: J Biol Chem Date: 2010-06-15 Impact factor: 5.157
Authors: Katarina Hajdin; Valentina D'Alessandro; Felix K Niggli; Beat W Schäfer; Michele Bernasconi Journal: PLoS One Date: 2010-05-03 Impact factor: 3.240
Authors: Ilya V Demidyuk; Andrey V Shubin; Eugene V Gasanov; Alexander M Kurinov; Vladimir V Demkin; Tatyana V Vinogradova; Marina V Zinovyeva; Alexander V Sass; Irina B Zborovskaya; Sergey V Kostrov Journal: PLoS One Date: 2013-02-07 Impact factor: 3.240